Even in the absence of morphological dysplasia, several chromosomal abnormalities and two mutations—biallelic TP53 and SF3B1 mutations—are considered MDS defining as per the WHO 5th edition (WHO5ED) criteria [1]. Here, TP53 is linked to myelodysplastic syndrome.